Read full report (PDF) Identifying timely topics and trends in the sub-$200 million market. Research Type: Emerging Timeliness: Current Date: July 28, 2023 MedX Health Corp. MDX $0.065TSXV Exchange | OTC:MDXHF …
MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that Stephen Lockyer has been appointed as Chief Executive Officer, effective immediately, in place of Naman Damaghlatrous, who has resigned both as an officer and director of the Company.
PharmaChoice Canada, one of Canada’s fastest‐growing pharmacy groups, with more than 1000
independent pharmacy owners and operators, announces its partnership with MedX Health to launch a
pilot program of MedX’s DermSecure® Screening Platform